NeoGenomics, Inc.
12701 Commonwealth Drive
Suite 9
Fort Myers
Florida
33913
United States
Tel: 239-768-0600
Fax: 239-768-0711
Website: http://www.neogenomics.org/
Email: info@neogenomics.org
268 articles about NeoGenomics, Inc.
-
NeoGenomics, Inc. Set To Join Russell 3000 Index
6/16/2015
-
NeoGenomics, Inc. Launches Twelve NeoLAB Liquid Biopsy" Tests For Hematologic Diseases
6/11/2015
-
NeoGenomics, Inc. Reports 27% Revenue Growth Driven By Strong Volume Gains And PathLogic Acquisition
4/28/2015
-
NeoGenomics, Inc. Announces Promotions
4/23/2015
-
NeoGenomics, Inc. Schedules Its Q1 2015 Earnings Release For April 28, 2015
4/17/2015
-
NeoGenomics, Inc. Reports Record Revenue Of $25.0 Million, Adjusted EBITDA Of $2.8 MM And Net Income Of $0.02 Per Share For The Fourth Quarter 2014
2/24/2015
-
NeoGenomics, Inc. Schedules Its Q4 2014 And Full Year 2014 Earnings Release For February 24, 2015
2/4/2015
-
NeoGenomics, Inc. Raises Revenue Guidance To $25 Million And EPS Guidance To $0.01 - $0.02 Per Hare For Quarter 4, 2014
1/23/2015
-
NeoGenomics, Inc., The Robert H. Lurie Comprehensive Cancer Center Of Northwestern University, And The Northwestern Medicine Developmental Therapeutics Institute Launch Collaborative Translational Research Program
12/16/2014
-
N-of-One Selected By NeoGenomics, Inc. To Provide Clinical Evidence For Interpreting Solid Tumor Next-Generation Sequencing Tests
12/2/2014
-
NeoGenomics, Inc. Reports 38% Increase In Revenue To A Record $23.2 Million And Adjusted EBITDA Of $2.6 Million For The Third Quarter Of 2014
10/30/2014
-
NeoGenomics, Inc. Is First To Offer Molecular Testing For Resistance To Bruton Tyrosin Kinase Inhibitors For Chronic Lymphocytic Leukemia
10/23/2014
-
NeoGenomics, Inc. Launches 315 Gene Next Generation Sequencing Test For Solid Tumor Discovery Profiling
10/16/2014
-
NeoGenomics, Inc. Appoints Robert J. Shovlin As Chief Operating Officer
9/30/2014
-
NeoGenomics, Inc. Announces Closing Of Recent Equity Offering And Exercise In Full Of Underwriters' Over-Allotment Option
8/22/2014
-
NeoGenomics, Inc. Announces Public Offering Of Common Stock
8/15/2014
-
NeoGenomics, Inc. Reports Record Revenues Of $20.7 Million On 40% Test Volume Growth And Expanding Gross Margins For The Second Quarter 2014
7/17/2014
-
NeoGenomics, Inc. Expands Next Generation Sequencing Services And Offers 23 Different Profiles For Various Hematologic And Solid Cancers
7/11/2014
-
NeoGenomics, Inc. Completes Acquisition Of Path Logic
7/9/2014
-
NeoGenomics, Inc. Raises Guidance And Projects 30% Year-Over-Year Revenue Growth In Quarter 2, 2014
6/23/2014